Answers are grounded in this paper and cite their sources.
The antibiofilm activity of oritavancin in combination with rifampin, gentamicin, or linezolid was evaluated against 10 prosthetic joint infection (PJI)-related methicillin-resistant Staphylococcus aureus (MRSA) isolates by time-kill assays. Oritavancin combined with rifampin demonstrated statistically significant bacterial reductions compared with those of either antimicrobial alone for all 10 isolates ( P ≤ 0.001), with synergy being observed for 80% of the isolates.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: